We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Adicet Bio Inc | NASDAQ:ACET | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 2.13% | 1.44 | 1.44 | 5.00 | 1.56 | 1.40 | 1.45 | 4,866,272 | 05:00:00 |
Details of the event are as follows: | |
Panel: | Gamma Delta CART-Cells, and “Squeezed” T-cells |
Date: | Thursday, April 15, 2021 |
Time: | 1:00 – 1:55 PM ET |
Format: | Panel moderated by John Newman, Ph.D., Managing Director, Biotechnology Analyst |
About Adicet Bio, Inc.Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.
Adicet Bio., Inc.Investor and Media ContactsAnne Bowdidgeabowdidge@adicetbio.com
Janhavi MohiteStern Investor Relations, Inc.212-362-1200janhavi.mohite@sternir.com
1 Year Adicet Bio Chart |
1 Month Adicet Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions